What is Lanreotide?
Category: Prescription Drugs
Most popular types: Somatuline Depot
Lanreotide is a somastatin analog it is used for the long-term treatment of acromegaly.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Acromegaly syndrome | 23 | 2 | |
| Neuroendocrine tumor | 13 | 0 | |
| Carcinoid syndrome | 7 | 0 | |
| Pancreatic neuroendocrine tumor | 6 | 1 | |
| Gastrointestinal neuroendocrine tumor | 5 | 0 | |
| Thyrotropinoma | 1 | 1 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 2 | |
| Moderate | 0 | |
| Mild | 2 | |
| None | 0 |
Commonly reported side effects and conditions associated with Lanreotide
| Side effect | Patients | Percentage |
|---|---|---|
| Injection site itching | 1 | |
| Injection site pain | 1 | |
| Lethargy | 1 | |
| Lump on back | 1 | |
| Non-diabetic hypoglycemia | 1 | |
| Stomach pain | 1 |
Why patients stopped taking Lanreotide
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Did not seem to work | 1 | |
| Doctor's advice | 1 | |
| Other | 1 | |
| Side effects too severe | 1 |
Duration
Stopped taking Lanreotide
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 1 | |
| 1 - 6 months | 1 | |
| 2 - 5 years | 2 |
What people switch to and from
Patients started taking Lanreotide after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Octreotide (Sandostatin) | 2 |
Patients stopped taking Lanreotide and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Capecitabine (Xeloda) | 1 | |
| Octreotide (Sandostatin) | 1 |
Last updated: